메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
김수현 (스튜어드 조셉병원) 류은정 (중앙대학교)
저널정보
대한종양간호학회 Asian Oncology Nursing Asian Oncology Nursing Vol.22 No.4
발행연도
2022.12
수록면
214 - 224 (11page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

이 논문의 연구 히스토리 (2)

초록· 키워드

오류제보하기
Purpose: This study aimed to evaluate the effectiveness of a combined management of lymphedema education (CMLE) program which was designed for the prevention of breast cancer related lymphedema. Methods: We applied a quasi-experimental study, pretest, and posttest design with a non-equivalent control group. Breast cancer survivors with partial or total mastectomy and axillary lymph node dissection were recruited and assigned to either an intervention or control group at S hospital in Seoul. The outcomes were measured using the Breast Cancer Lymphedema Symptom Experience Index, Lymphedema Risk Reduction Behavior Checklist, Patients Activation Measure 13, Functional assessment of cancer therapy-General, and Disabilities of the Arm, Shoulder and Hand. The circumferences of both arms were measured by a nurse. These measurements were conducted and compared at baseline and two weeks after completing the (CMLE) program. Results: There were statistically significant changes in quality of life, physical wellbeing, and lymphedema risk behaviors in both groups after the CMLE program. There were significant differences in the circumference of right forearm, elbow, and upper arm between the two groups. Conclusion: It can be concluded that the CMLE program is viable tool to prevent and manage breast cancer related lymphedema and is effective in improving the quality of life in breast cancer survivors with axillary lymph node dissection.

목차

서론
연구방법
연구결과
논의
결론 및 제언
REFERENCES

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2023-512-000335354